Agios Pharma (AGIO) Reports Q4 Loss of $1.08/Share

Agios Pharma (NASDAQ: AGIO) reported Q4 EPS of ($1.08), versus ($0.76) reported last year. Revenue for the quarter came in at $6.22 million, versus $14.64 million reported last year.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• XP Inc. (XP) Tops Q2 EPS by 8c
• The LGL Group (LGL) Misses Q2 EPS by 8c